International Journal of Prostate Cancer

About The Journal

International Journal of Prostate Cancer (IJPC) is a premier open access, peer-reviewed journal dedicated to advancing the understanding and treatment of prostate cancer. Our mission is to disseminate cutting-edge research and clinical insights to a global audience, fostering collaboration and innovation in the field. IJPC publishes a diverse range of content, including original research articles, comprehensive reviews, insightful editorials, and detailed case reports, all focused on prostatic neoplasms and their management.
 

Scope and Focus

IJPC is committed to providing the latest advancements in prostate cancer research, from novel diagnostic techniques to emerging therapeutic strategies. Our journal serves as a dynamic platform for scholarly exchange, offering readers access to groundbreaking studies, critical reviews, and expert opinions. We aim to facilitate meaningful discussions and debates that drive progress in prostate cancer care.
 

Submission Process

We welcome submissions from researchers, clinicians, and industry professionals globally. All manuscripts undergo a rigorous single-blind peer review process, with publication decisions based on scientific merit. Accepted papers are published with open access, maximizing their visibility and impact. Authors can submit their manuscripts through the journal's online submission system, via email, or through Manuscript Zone.

IJPC invites contributions that enhance the understanding of prostate cancer, including original research, reviews, case reports, short communications, and editorials. Join us in our mission to advance prostate cancer research and improve patient outcomes.
 

Submission Guidelines

We uphold the highest standards of scientific integrity and rigor. Manuscripts should be original, well-researched, and written in clear, concise English. Submissions must adhere to our guidelines, which align with the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) recommendations. Manuscripts should not exceed 6000 words, excluding abstracts, references, and figures. Please submit your work via our online submission system.
 

Author Benefits

Authors who publish with IJPC enjoy numerous advantages, including:

• Wide Reach: Open access ensures your work is accessible to researchers, clinicians, and policymakers worldwide.
• Rapid Publication: Our efficient review process guarantees timely dissemination of your research.
• Collaborative Review: We promote open peer review, encouraging transparency and constructive feedback.
• Comprehensive Support: Authors receive guidance throughout the submission and publication process.

Editorial Excellence

Our esteemed Editorial Board comprises leading experts in prostate cancer research from around the world. They are dedicated to ensuring the quality and relevance of the content we publish. The board's diverse expertise spans various aspects of prostate cancer, from basic science to clinical practice, ensuring a comprehensive and multidisciplinary approach.
 

Article Processing Charges

To maintain the high quality of our journal and ensure open access, we charge a minimal Article Processing Charge. This fee supports the production and publication process, allowing us to provide valuable content to our readers without barriers.
 

Contact Us

For any inquiries, please contact us via email.